Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence

International Journal of Cancer

Volumn 133, Issue 5, 2013, Pages 1023-1032

  González, Carlos A ^a   Sanz Anquela, José M ^b   Gisbert, Javier P ^c   Correa, Pelayo ^d,e  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

gastric cancer; intestinal metaplasia; review; subtypes

Indexed keywords

CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RISK; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; FOLLOW UP; HISTOLOGY; HUMAN; INTESTINE METAPLASIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; SYSTEMATIC REVIEW;

GASTRIC CANCER; INTESTINAL METAPLASIA; REVIEW; SUBTYPES;

BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; HUMANS; INTESTINES; METAPLASIA; PRECANCEROUS CONDITIONS; RISK; STOMACH NEOPLASMS;

EID: 84879201093     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28003     Document Type: Review

References (46)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Axon A,. Symptoms and diagnosis of gastric cancer at early curable stage. Best Pract Res Clin Gastroenterol 2006; 20: 697-708.
3. Correa P,. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19: S37-S43.
4. Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2: 58-60.
5. Correa P, Piazuelo MB, Wilson KT,. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010; 105: 493-8.
6. Teglbjaerg PS, Nielsen HO,. "Small intestinal type" and "colonic type" intestinal metaplasia of the human stomach, and their relationship to the histogenetic types of gastric adenocarcinoma. Acta Pathol Microbiol Scand A 1978; 86A: 351-5.
7. Matsukura N, Kawachi T, Sugimura T, et al. Variety of phenotypical expression of intestinal marker enzymes and mucins in human stomach intestinal metaplasia. Acta Histochem Cytochem Jap 1980; 13: 499-507.
8. Jass JR, Filipe MI,. A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology 1979; 3: 191-9.
9. Busuttil RA, Boussioutas A,. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol 2009; 24: 193-201.
10. de Vries AC, Haringsma J, Kuipers EJ,. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007; 12: 1-15. Review.
11. Hirota WK, Zuckerman MJ, Adler DG, et al. Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006; 63: 570-80.
12. The Royal College of Pathologists. Histopathology and cytopathology of limited or no clinical value, 2nd edn. London, UK, 2005.
13. Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94.
14. Kang KP, Lee HS, Kim N, et al. Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea. J Gastroenterol Hepatol 2009; 24: 140-8.
15. Vukobrat-Bijedic̈ Z, Radovic̈ S, Husic̈-Selimovic̈ A, et al. Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of Helicobacter pylori positive chronic atrophic gastritis. Bosn J Basic Med Sci 2006; 6: 48-53.
16. Cassaro M, Rugge M, Gutierrez O, et al. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000; 95: 1431-38.
17. Wu MS, Shun CT, Lee WC, et al. Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia. Br J Cancer 1998; 78: 125-8.
18. Craanen ME, Blok P, Dekker W, et al. Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa. Dig Dis Sci 1991; 36: 1529-36.
19. Matsukuma A, Mori M, Enjoji M,. Sulphomucin-secreting intestinal metaplasia in the human gastric mucosa. An association with intestinal-type gastric carcinoma. Cancer 1990; 66: 689-94.
20. Kini U, Nirmala V, Thomas JA,. Intestinal metaplasia in benign and malignant gastric lesions. Indian J Pathol Microbiol 1990; 33: 137-43.
21. Sirigu F, Dessì A, Tocco G, et al. Intestinal metaplasia of the gastric mucosa: a study of its incidence in various disease states. Riv Eur Sci Med Farmacol 1991; 13: 25-8.
22. Silva S, Filipe MI,. Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects: a comparative analysis of biopsy and gastrectomy material. Hum Pathol 1986; 17: 988-95.
23. Huang CB, Xu J, Huang JF, et al. Sulphomucin colonic type intestinal metaplasia and carcinoma in the stomach. A histochemical study of 115 cases obtained by biopsy. Cancer 1986; 57: 1370-5.
24. Rothery GA, Day DW,. Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa. J Clin Pathol 1985; 38: 613-21.
25. Filipe MI, Potet F, Bogomoletz WV, et al. Incomplete sulphomucin- secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut 1985; 26: 1319-26.
26. Sipponen P, Seppälä K, Varis K, et al. Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Pathol Microbiol Scand A 1980; 88: 217-24.
27. Matsukura N, Suzuki K, Kawachi T, et al. Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. J Natl Cancer Inst 1980; 65: 231-40.
28. González CA, Pardo ML, Liso JM, et al. Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Int J Cancer 2010; 127: 2654-60.
29. Tava F, Luinetti O, Ghigna MR, et al. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia. Hum Pathol 2006; 37: 1489-97.
30. Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol 2004; 57: 177-82.
31. El-Zimaity HM, Ramchatesingh J, Saeed MA, et al. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol 2001; 54: 679-83.
32. Lin CK, Lai KH, Lo GH, et al. Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach. Zhonghua Yi Xue Za Zhi 2001; 64: 331-6.
33. Filipe MI, Muñoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994; 57: 324-9.
34. Rokkas T, Filipe MI, Sladen GE,. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991; 32: 1110-3.
35. Silva S, Filipe MI, Pinho A,. Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study. Gut 1990; 31: 1097-104.
36. Ramesar KC, Sanders DS, Hopwood D,. Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma. J Clin Pathol 1987; 40: 1287-90.
37. Ectors N, Dixon MF,. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 1986; 10: 1271-7.
38. Conchillo JM, Houben G, de Bruïne A, Stockbrügger R,. Is type III intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma? Eur J Cancer Prev 2001; 10: 307-12.
39. Turani H, Lurie B, Chaimoff C, et al. The diagnostic significance of sulfated acid mucin content in gastric intestinal metaplasia with early gastric cancer. Am J Gastroenterol 1986; 81: 343-5.
40. Lida F, Kusama J,. Gastric carcinoma and intestinal metaplasia. Significance of types of intestinal metaplasia upon development of gastric carcinoma. Cancer 1982; 50: 2854-8.
41. Tosi P, Filipe MI, Luzi P, et al. Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry. J Pathol 1993; 169: 73-8.
42. de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134: 945-52.
43. Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-6.
44. Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010; 31: 1104-11.
45. Capelle LG, de Vries AC, Haringsma J, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010; 71: 1150-8.
46. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.